Abstract:Abstract-The role of vascular cells during inflammation is critical and is of particular importance in inflammatorydiseases, including atherosclerosis, ischemia/reperfusion, and septic shock. Research in vascular biology has progressed remarkably in the last decade, resulting in a better understanding of the vascular cell responses to inflammatory stimuli. Most of the vascular inflammatory responses are mediated through the IB/nuclear factor-B system. Much recent work shows that vascular inflammation can be li… Show more
“…Normal mesenchymal lining cells (11) and OA synovial fibroblasts express IL-10R␣. In RA synovium, we observed that the expression of IL-10R␣ (if any) was mainly restricted to the perivascular region, in spite of the fact that a previous study (12) demonstrated that normal vascular tissue does not show IL-10R␣. Already this difference reflects a pathologic alteration and could also explain the lack of quantitative difference in IL-10R␣ mRNA using whole synovial tissues (i.e., neoangiogenesis being an important pathophysiologic process in RA).…”
“…Normal mesenchymal lining cells (11) and OA synovial fibroblasts express IL-10R␣. In RA synovium, we observed that the expression of IL-10R␣ (if any) was mainly restricted to the perivascular region, in spite of the fact that a previous study (12) demonstrated that normal vascular tissue does not show IL-10R␣. Already this difference reflects a pathologic alteration and could also explain the lack of quantitative difference in IL-10R␣ mRNA using whole synovial tissues (i.e., neoangiogenesis being an important pathophysiologic process in RA).…”
“…Most anti-inflammatory mechanisms in the vascular wall, including IL-10, TGF-, high density lipoprotein, and peroxisome proliferator-activated receptor ␣ activators, are mediated by inhibition of the NF-B pathway (31). IL-10 decreases leukocyte vein extravasation through inhibition of endothelial expression of P-selectin, E-selectin, and ICAM-1 (32).…”
Background: Interleukin-35 is a novel inhibitory cytokine. Results: Interleukin-35 inhibits vascular endothelial cell activation by suppressing MAPK-AP1-mediated VACM-1 expression in LPS-induced acute inflammation. Conclusion: Interleukin-35 suppresses acute vascular endothelium response. Significance: Interleukin-35 may be an attractive reagent for anti-inflammatory therapy.
“…Regional differences in cytokine-induced release and responsiveness to mediators appear to contribute to the dilator or constrictor responses observed in a specific vascular bed (42). Vascular cells may also respond to antiinflammatory counterregulatory mechanisms, including antiinflammatory cytokines, which maintain vascular wall integrity and homeostasis (40,42). IL-10, one of the main anti-inflammatory cytokines, displays vasculoprotective properties (42), and we can speculate that IL-10 is playing an important role, i.e., preventing ET-1-induced vascular injuries.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.